西南国防医药2012，Vol.22Issue(10)：1084-1086,3.DOI:10.3969/j.issn.1004-0188.2012.10.017
阿托伐他汀对急性冠脉综合征患者hs-CRP浓度的影响
Effects of atorvastain on hs-CRP concentration of patients with acute coronary syndrome
曾俊波 1杨汉东1
作者信息
- 1. 430060武汉,武汉大学人民医院心内科
- 折叠
摘要
Abstract
Objective To observe the effects of small dose of atorvastain (20 mg) on the high sensitive C reactive protein (hs - CRP) concentration of patients with acute coronary syndrome (ACS). Methods One hundred patients with ACS were randomly divided into treatment group and control group according to random, double blind, and control method. The treatment group was treated with atorvastain (20 mg, once a day) for 4 w and also received the conventional anti - angina treatment. The control group only received the conventional anti - angina treatment. Results The hs - CRP concentration in the treatment group and the control group all decreased, but the decrease in the treatment group was more significant. Subgroup analysis indicated that the decrease of hs - CRP was more significant among patients without the history of smoking, hypertension and angiocardiopathy in the treatment group. Conclusion In the early treatment phase of patients with ACS, a small dose of atorvastain (20 mg) can obtain good treatment effects.关键词
阿托伐他汀/高敏C反应蛋白/治疗Key words
atorvastain/ high sensitive C reactive protein/ treatment分类
医药卫生引用本文复制引用
曾俊波,杨汉东..阿托伐他汀对急性冠脉综合征患者hs-CRP浓度的影响[J].西南国防医药,2012,22(10):1084-1086,3.
